Package for an ophthalmic product
Latest Novartis AG Patents:
- Crystalline forms of a LTA4H inhibitor
- Crystalline forms of potassium channel modulators
- Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodies
- Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
- CD19 and CD22 chimeric antigen receptors and uses thereof
Description
Claims
The ornamental design for a package for an ophthalmic product, as shown and described.
Referenced Cited
U.S. Patent Documents
2421748 | June 1947 | Fink |
2936944 | May 1960 | Arlington |
D205970 | October 1966 | Leifield |
3389847 | June 1968 | Darot |
D217502 | May 1970 | Valerie |
4007828 | February 15, 1977 | Mayled |
4799588 | January 24, 1989 | Trisl |
5582293 | December 10, 1996 | Kay |
D383064 | September 2, 1997 | Tsukikawa |
D398527 | September 22, 1998 | Maceachern et al. |
5855345 | January 5, 1999 | DiMaggio |
20060266672 | November 30, 2006 | Young |
20070227943 | October 4, 2007 | Foushee |
Patent History
Patent number: D574230
Type: Grant
Filed: Oct 12, 2006
Date of Patent: Aug 5, 2008
Assignee: Novartis AG (Basel)
Inventors: Vincent Bowman (Highland Park, IL), Larbi van Lier (Cumming, GA)
Primary Examiner: Catherine Tuttle
Attorney: Robert Ambrose
Application Number: 29/249,565
Type: Grant
Filed: Oct 12, 2006
Date of Patent: Aug 5, 2008
Assignee: Novartis AG (Basel)
Inventors: Vincent Bowman (Highland Park, IL), Larbi van Lier (Cumming, GA)
Primary Examiner: Catherine Tuttle
Attorney: Robert Ambrose
Application Number: 29/249,565
Classifications
Current U.S. Class:
D9/418